EUCTR2012-005359-18-ITActive, not recruitingNot Applicable
Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study - RIVENDE
IVERSITA' CAMPUS BIOMEDICO0 sitesStarted: December 21, 2012Last updated:
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •ISCHEMIC HEART DISEASE PATIENTS TREATED WITH CORONARY ANGIOPLASTY AND ON TOP OF MEDICAL TREATMENT
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 70
Exclusion Criteria
- •Patients with resting heart rate <60 bpm.
- •Patients undergoing revascularization for STEMI.
- •Patients with severe left ventricular dysfunction (ejection fraction = 35%).
- •Patients with chronic renal failure, severe (GFR <60 ml / min).
- •Patients with liver disease.
- •Patients with atrial fibrillation and atrial flutter.
- •Patients with pacemakers.
- •Patients with disease of the sinoatrial node, sinoatrial block, long QT syndrome, complete AV block.
- •Patients with chronic inflammatory disease and cancer.
Investigators
Similar Trials
Completed
Not Applicable
Trial of ivabradine for controlling high heart rate control in septic shock.CTRI/2017/09/009849All India Institute of Medical Sciences New Delhi60
Not yet recruiting
Not Applicable
Role of Ivabradine in reducing tachycardia induced adverse outcomes in severe septic shockCTRI/2022/01/039557Calcutta national medical college
Completed
Phase 4
Ivabradine to Improve Endothelial Function in Patients With Coronary Artery DiseaseCoronary Artery DiseaseNCT02681978Campus Bio-Medico University70
Active, not recruiting
Not Applicable
Senkung einer erhöhten Herzfrequenz durch Ivabradin bei Patienten mit Multiorgandysfunktionssyndrom. - MODIfYPatienten mit MODS (Multiorgandysfunktionssyndrom)EUCTR2009-015499-88-DEMartin-Luther-Universität Halle-Wittenberg
Completed
Not Applicable
Effect of cardiac drug ivabradine on heart rate and blood pressure stability in patients undergoing off pump Coronary Artery Bypass surgery.CTRI/2015/06/005858G B Pant Hospital50